human pbmcs Search Results


99
ATCC normal human primary peripheral blood mononuclear cells pbmcs
Normal Human Primary Peripheral Blood Mononuclear Cells Pbmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pmc13022387-202-0-8?v=ATCC
Average 99 stars, based on 1 article reviews
normal human primary peripheral blood mononuclear cells pbmcs - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

94
Miltenyi Biotec macsprep pbmc isolation kit
Macsprep Pbmc Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/10__1016_slash_j__jff__2026__107293-81-9-13?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
macsprep pbmc isolation kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

96
Beijing Solarbio Science flow cytometric analysis fresh human peripheral blood mononuclear cells pbmcs
Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh <t>PBMCs</t> were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002
Flow Cytometric Analysis Fresh Human Peripheral Blood Mononuclear Cells Pbmcs, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pm22438812-313-0-17?v=Beijing+Solarbio+Science
Average 96 stars, based on 1 article reviews
flow cytometric analysis fresh human peripheral blood mononuclear cells pbmcs - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

92
Miltenyi Biotec straightfrom leukopak pbmc isolation kit miltenyi biotec
Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh <t>PBMCs</t> were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002
Straightfrom Leukopak Pbmc Isolation Kit Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pm38508197-495-155-160?v=Miltenyi+Biotec
Average 92 stars, based on 1 article reviews
straightfrom leukopak pbmc isolation kit miltenyi biotec - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

94
Miltenyi Biotec custom buffy coat lrsc pbmc isolation kit
Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh <t>PBMCs</t> were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002
Custom Buffy Coat Lrsc Pbmc Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/us12522639-1412-25-31?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
custom buffy coat lrsc pbmc isolation kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

97
Miltenyi Biotec reafinitytm
Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh <t>PBMCs</t> were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002
Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pmc12589992-84-7-9?v=Miltenyi+Biotec
Average 97 stars, based on 1 article reviews
reafinitytm - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

93
Miltenyi Biotec custom whole blood pbmc iso kit
Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh <t>PBMCs</t> were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002
Custom Whole Blood Pbmc Iso Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pm37958436-91-21-27?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
custom whole blood pbmc iso kit - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

86
Human Protein Atlas pbmc
(a) The S3WP cohort comprises 101 clinically healthy individuals characterized by longitudinal multi-omics profiling. Repeated measurements from the same individual enabled assessments of intra-and inter-individual immune variation and cross-omic integration. (b) The participants were followed longitudinally across six visits over two years. At each visit, PBMCs and plasma samples were collected for CyTOF, RNA-seq, and Olink proteome profiling; WGS was performed at baseline. (c) Sex distribution of the participants. (d) Age distribution at enrollment. (e) Frequency distributions of 18 major immune cell populations derived from CyTOF analysis across all samples. (f) UMAP clustering of <t>PBMC</t> <t>transcriptomics</t> <t>profiles</t> from the S3WP cohort alongside immune-cell transcriptomics from the Human Protein Atlas. Colors indicate immune cell populations.
Pbmc, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/bio_rxiv__64898__2026__03__21__713378-34-21-30?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
pbmc - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

93
iXCells Biotechnologies 10hu 003 cr10m 10hu 003 cr100m

10hu 003 Cr10m 10hu 003 Cr100m, supplied by iXCells Biotechnologies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pmc11648265-455-15-13?v=iXCells+Biotechnologies
Average 93 stars, based on 1 article reviews
10hu 003 cr10m 10hu 003 cr100m - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

94
Cell Applications Inc hpbmc

Hpbmc, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/us11702621-169-4-10?v=Cell+Applications+Inc
Average 94 stars, based on 1 article reviews
hpbmc - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
iQ Biosciences macaque pbmcs human

Macaque Pbmcs Human, supplied by iQ Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/pmc10798159__DataSheet_1-47-8-11?v=iQ+Biosciences
Average 94 stars, based on 1 article reviews
macaque pbmcs human - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Innovative Research Inc peripheral blood mononuclear cells

Peripheral Blood Mononuclear Cells, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pbmcs/us10696950-355-11-16?v=Innovative+Research+Inc
Average 93 stars, based on 1 article reviews
peripheral blood mononuclear cells - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh PBMCs were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002

Journal: PLoS pathogens

Article Title: TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

doi: 10.1371/journal.ppat.1002594

Figure Lengend Snippet: Figure 2. Deficient NK cell function in IT patients. (A) Deficient NK cell cytotoxicity from IT patients. NK cell cytotoxicity was assessed in primary NK cells from IT, IA, and IN patients and healthy controls using a 51Cr-release assay with K562 target cells. (B) Results show the mean 6 SEM values in 19 patients and 5 controls. Values for IT patients were less than controls (P= 0.0384). (C) Positive correlation between NK cell cytotoxicity and the percentage of NK cells expressing NKG2D and 2B4. (D) Fresh PBMCs were stimulated with/without IL-12 as described in the Materials and Methods. After 16 h, IFN-c production was determined using flow cytometry by gating on CD32CD56+ NK cells. A representative dot plot displaying intracellular IFNc staining in NK cells with the subsets indicated is shown. (E) Cumulative data are shown. (F, G) Fresh PBMCs from patients before treatment (black) or after treatment (white) were stimulated with IL-12 for 16 h. IFNc (F) and CD107a (G) production was determined using flow cytometry by gating on CD32CD56+ NK cells. (H) Induction of ex vivo NK cell cytotoxic activity after in vivo administration of antiviral treatment with nucleoside analogues until ALT reached normal levels. NK cytotoxicity was determined ex vivo by measuring the lysis of 51Cr-labelled target cells before treatment (red) or after treatment (green). Cumulative data are shown. doi:10.1371/journal.ppat.1002594.g002

Article Snippet: Flow cytometric analysis Fresh human peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood by Ficoll-Isopaque (Solarbio, China) gradient centrifugation.

Techniques: Cell Function Assay, Release Assay, Expressing, Flow Cytometry, Staining, Ex Vivo, Activity Assay, In Vivo, Analogues, Lysis

(a) The S3WP cohort comprises 101 clinically healthy individuals characterized by longitudinal multi-omics profiling. Repeated measurements from the same individual enabled assessments of intra-and inter-individual immune variation and cross-omic integration. (b) The participants were followed longitudinally across six visits over two years. At each visit, PBMCs and plasma samples were collected for CyTOF, RNA-seq, and Olink proteome profiling; WGS was performed at baseline. (c) Sex distribution of the participants. (d) Age distribution at enrollment. (e) Frequency distributions of 18 major immune cell populations derived from CyTOF analysis across all samples. (f) UMAP clustering of PBMC transcriptomics profiles from the S3WP cohort alongside immune-cell transcriptomics from the Human Protein Atlas. Colors indicate immune cell populations.

Journal: bioRxiv

Article Title: Systems-level longitudinal immune profiling reveals individualized immunotypes and genetic associations

doi: 10.64898/2026.03.21.713378

Figure Lengend Snippet: (a) The S3WP cohort comprises 101 clinically healthy individuals characterized by longitudinal multi-omics profiling. Repeated measurements from the same individual enabled assessments of intra-and inter-individual immune variation and cross-omic integration. (b) The participants were followed longitudinally across six visits over two years. At each visit, PBMCs and plasma samples were collected for CyTOF, RNA-seq, and Olink proteome profiling; WGS was performed at baseline. (c) Sex distribution of the participants. (d) Age distribution at enrollment. (e) Frequency distributions of 18 major immune cell populations derived from CyTOF analysis across all samples. (f) UMAP clustering of PBMC transcriptomics profiles from the S3WP cohort alongside immune-cell transcriptomics from the Human Protein Atlas. Colors indicate immune cell populations.

Article Snippet: To assess the quality of the PBMC transcriptomics data, we compared the PBMC transcriptomic profiles from the S3WP study with the PBMC and 18 flow-sorted immune cell transcriptomes from the Human Protein Atlas (HPA) ; as expected, the PBMC samples from the S3WP project were clustered together with PBMC samples from the HPA ( ).

Techniques: Biomarker Discovery, Clinical Proteomics, RNA Sequencing, Derivative Assay, Transcriptomics

(a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of transcriptomic data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.

Journal: bioRxiv

Article Title: Systems-level longitudinal immune profiling reveals individualized immunotypes and genetic associations

doi: 10.64898/2026.03.21.713378

Figure Lengend Snippet: (a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of transcriptomic data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.

Article Snippet: To assess the quality of the PBMC transcriptomics data, we compared the PBMC transcriptomic profiles from the S3WP study with the PBMC and 18 flow-sorted immune cell transcriptomes from the Human Protein Atlas (HPA) ; as expected, the PBMC samples from the S3WP project were clustered together with PBMC samples from the HPA ( ).

Techniques: Gene Expression, Clinical Proteomics, Expressing

(a) t-SNE sample clustering based on transcriptomic profiles of genes in the PBMC association network. (b) Immune frequencies patterns across the three sample clusters. (c) Distribution of (top) innate immune cell frequencies and (bottom) CD4:CD8 ratio across the three clusters. (d) Immune frequencies of the modules in the PBMC network, divided by sample clusters. (e) Number of up- and down-regulated genes in each module (FDR<0.05) obtained from differential expression analysis between each cluster and the remaining two. (f-h) t-SNE clustering colored based on CD4:CD8+ T cells ratio, and immune frequencies of the B cells, cytotoxic and myeloid modules. (j) (Top) CRP levels of participant P3920. (Bottom) Sample clusters of participants across visits; highlighted in black are the samples from participant P3920. (k) Pattern of clinical variables across the three clusters. (l) Patterns of the 30 proteins with the most significant up-regulation in any of the three clusters. SBP, systolic blood pressure; DBP, diastolic blood pressure; TNT, troponin T; CRP, C-reactive protein; HDL, high density lipoprotein; ALAT, alanine aminotransferase; GGT, gamma-glutamyl transferase. P-values are calculated by Wilcoxon tests in c-d; ns, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: bioRxiv

Article Title: Systems-level longitudinal immune profiling reveals individualized immunotypes and genetic associations

doi: 10.64898/2026.03.21.713378

Figure Lengend Snippet: (a) t-SNE sample clustering based on transcriptomic profiles of genes in the PBMC association network. (b) Immune frequencies patterns across the three sample clusters. (c) Distribution of (top) innate immune cell frequencies and (bottom) CD4:CD8 ratio across the three clusters. (d) Immune frequencies of the modules in the PBMC network, divided by sample clusters. (e) Number of up- and down-regulated genes in each module (FDR<0.05) obtained from differential expression analysis between each cluster and the remaining two. (f-h) t-SNE clustering colored based on CD4:CD8+ T cells ratio, and immune frequencies of the B cells, cytotoxic and myeloid modules. (j) (Top) CRP levels of participant P3920. (Bottom) Sample clusters of participants across visits; highlighted in black are the samples from participant P3920. (k) Pattern of clinical variables across the three clusters. (l) Patterns of the 30 proteins with the most significant up-regulation in any of the three clusters. SBP, systolic blood pressure; DBP, diastolic blood pressure; TNT, troponin T; CRP, C-reactive protein; HDL, high density lipoprotein; ALAT, alanine aminotransferase; GGT, gamma-glutamyl transferase. P-values are calculated by Wilcoxon tests in c-d; ns, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: To assess the quality of the PBMC transcriptomics data, we compared the PBMC transcriptomic profiles from the S3WP study with the PBMC and 18 flow-sorted immune cell transcriptomes from the Human Protein Atlas (HPA) ; as expected, the PBMC samples from the S3WP project were clustered together with PBMC samples from the HPA ( ).

Techniques: Quantitative Proteomics

Journal: iScience

Article Title: A combined AI and cell biology approach surfaces targets and mechanistically distinct Inflammasome inhibitors

doi: 10.1016/j.isci.2024.111404

Figure Lengend Snippet:

Article Snippet: Isolated cells from male and female donors aged 45–55 were acquired commercially from iXCells Biotechnology (10HU-003-CR10M, 10HU-003-CR100M).

Techniques: Recombinant, Software